Medical Material Waste Disposal Concept Stocks
Are you also looking for information on Medical Material Waste Disposal Concept Stocks, that's right, I've carefully compiled this Medical Material Waste Disposal Concept Stocks article, it should be able to answer your questions, and more Medical Material Waste Disposal Concept Stocks related to the information, you can search in the upper right corner.
Medical Material Waste Disposal Concept Stocks
Medical Material Waste Disposal Concept Stocks Include:
__Huahong Science and Technology: the stock's highlight is the technology leader in the field of renewable resource utilization, with a complete system of renewable resource recycling, processing and remanufacturing.
__Innitech: The highlight of the stock is a high-tech enterprise focusing on the research, development and production of sanitation equipment and products.
___Pharmasite: The highlight of the stock is to occupy a place in the field of biomedicine by virtue of its excellent technology and products.
__Weiming Environmental Protection: The highlight of the stock is that it owns a perfect recycling system of used home appliances and lithium cobaltate.
__Greenmax: The highlight of the stock is the high market share of ternary precursor materials.
__Xianle Health: The highlight of the stock is that it specializes in the research, development, production and sales of nutritional and health foods.
The above mentioned medical material waste treatment concept stocks, whose business scope covers the complete industry chain from the recovery of waste materials, processing to remanufacturing, or have advanced technology and products, or have already achieved a certain market share in related fields. The fundamental and technical performance of these companies may fluctuate with market changes, so please analyze carefully and seek professional advice before investing.
Medical supplies price hike concept stocks
Medical supplies price hike concept stocks include, but are not limited to, the following:
______ Meiyingsen. ____ The company has partnered with Alcon Bio to provide it with packaging materials. The recombinant new coronavirus protein vaccine (Sf9 cells) of Aikang Biologicals has been approved by the Biological Products Licensing Office of the Ministry of Health of Indonesia for emergency use authorization, and the vaccine will be gradually launched in Southeast Asia, Europe and the United States market in the following period. Meiyingsen has the production capacity of anti-counterfeit packaging, which can send the drugs produced by the company's customers to overseas suppliers, and the company can become a qualified supplier of vaccines to its pharmaceutical companies in the vaccine production process.
______ Squire Sanders Pharmaceuticals. ____ participation in the company's new Sheridan Pharmaceuticals, focusing on research and development and production of traditional Chinese medicine products, the treatment of the new crown drug "Henan oil formula" of the exclusive clinical authorization. Squire Sanders chairman of the board of directors said on March 24 to accept institutional research, the company has been to a number of provinces and municipalities eligible for small and medium-sized enterprises, health care workers, 120 ambulance fleet and other groups of distribution and distribution of "Henan oil formula" Chinese medicine granules products.
______ Guangshengtang. ____ holding subsidiary Guangshengtang Pharmaceutical Company has been to the Fujian Province, Quanzhou City, Xiamen City and Fuzhou City, Fujian Province, part of the hospital cumulative sales of new crown treatment drugs lopiravir, ritonavir 1220 boxes, the value of 1,166,300 yuan.
______ Kangtai Medical. ____ The company produces and sells masks, protective clothing, medical gloves, medical caps and other products, which can fully correspond to the four major use scenarios, such as the front line of diagnosis and treatment of the new crown outbreak, the new crown vaccination sites, square cabin hospitals and centralized isolation sites.
______ UWG. ____2020 after the new crown outbreak, the company's FireEye laboratory can test 1,000 samples per day, as of January 2021 data, the company has accumulated for more than 150 countries and regions around the world to provide the new crown nucleic acid testing services.
Note, investment is risky, choose carefully.
Medical material production concept stocks
The following are some of the medical material production concept stocks:
__Yuyue Medical: Its products cover the full range of medical and healthcare fields such as home healthcare, clinical healthcare, and internet healthcare, and it continues to seek innovations in other medical device segments.
__ Baolite: Its products such as monitors, multi-parameter blood analyzers, and urodynamometers have a high market share in the medical industry, and it also produces hemodialysis fluids, reusable equipment, medical oxygen supply and accessories, and ward care equipment and appliances.
__ Southwind: one of the main manufacturers of dust masks and gas masks in China, accounting for more than 20% of the domestic market share.
__ Hitech Bio: its eszopiclone, doxazosin mesylate extended-release tablets, bunanserin oral solution, simvastatin tablets, paliperidone extended-release tablets, dexamethasone cream and other products are mainly used in the treatment of mental diseases and cardiovascular and cerebrovascular diseases.
__ Health Yuan: Its injectable products include Gabexate Mesylate for Injection, Lactacystin for Injection, Recombinant Human Interleukin-2 (DNA Recombinant) for Injection, etc., which are mainly used in the treatment of cardio-cerebral and cerebral vascular diseases, as well as gynecological miscellaneous diseases.
__XinKaipu: Its near-infrared head-mounted sensors have been used in medical fields such as blood oxygen saturation testing.
__ Wanbangde: Qingdao Yaoneng, a subsidiary of Wanbangde, has begun to provide "portable oxygen inhalation" service in non-public medical institutions to help patients solve oxygen inhalation problems.
Please note that the above information is for reference only, investment is risky, please be careful when entering the market.
Medical supplies shortage of leading stocks
Medical supplies shortage of stocks are:
1. Medical dressings category: Changshan Beiming, Yingtai Group, Jiaying Pharmaceuticals, Dongfang Biologicals, MediKai, Zhijiang Biologicals, Duane Genetics, ST Daji, Changhong Science and Technology, the new industry, Aotai Biologicals, new photoelectricity, Wanbangde, Hanyu Pharmaceuticals, Ribon Instruments, Shanhe Pharmaceutical Auxiliary, Myriad Medical, Lafan Medical, Hualan Biologicals, Wanbangda and so on.
2. Protective clothing and masks: Xinlong Holdings, Jiangnan Group, TEDA shares, the Airport Economic Zone, st Meisheng, Tianbao infrastructure, China Qingbao and so on.
3. Pharmaceutical industry-related: China Pharmaceutical, Panlong Pharmaceutical, Teyi Pharmaceutical, Hulu, Kangtai Biotechnology, Wohua Pharmaceutical, Qianjin Pharmaceutical, Renhe Pharmaceutical, Xinhua Pharmaceutical, Meikang Pharmaceutical and so on.
The above are just some of the stocks, the shortage of medical supplies may have an impact on the relevant industries, investors should be careful to invest according to their own situation.
Medical supplies concept leading stocks
Medical supplies concept leading stocks include:
1. TEDA shares: the company has masks protective clothing and other anti-epidemic supplies production capacity.
2. Xinlong Holdings: the company produces medical masks, disinfectant solution, disinfectant effervescent tablets and other anti-epidemic supplies.
3. Blue Dawn Technology: the company's adsorbent material products are mainly used in ion exchange resins, adsorbent separation materials and catalysts, applied to medical, environmental protection, metallurgy and catalysts and other fields.
4. Hazanlian: the company has rich pharmaceutical R&D technology and production experience, has developed many varieties such as Azulfidine tablets, and some products are exported overseas.
5. Lanwei Medical: The company is one of the well-known medical testing outsourcing service providers in China, providing testing and technical services, with independent medical laboratories as well as GMP production workshops.
6. Weiguang Bio: the company is a high-tech enterprise engaged in the business of vaccines, blood products, biologics, in vitro diagnostic reagents and equipment, etc. Its core products include tetanus immune globulin, rabies immune globulin, hydrostatic human immune globulin, histamine human immune globulin, encephalitis B vaccine, diphtheria vaccine, whooping cough vaccine and so on.
7. Anti-Park Technology: The company is an artificial intelligence enterprise focusing on the field of medical and health care, and its main product is a portable intelligent health monitoring device based on artificial intelligence technology and big data technology.
The above is for reference only, investment risk, please be careful when entering the market.
That's it for the introduction of medical material waste disposal concept stocks.